Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

recurrent Malignant Mesothelioma

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Treatment of Recurrent Malignant Mesothelioma

Broader topic: Malignant Mesothelioma

Source population
Not part of this definition
Disease extent
recurrent
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
    1. class
      prior therapy
      status
      stated
    derivation status
    source-attested
    derivation note
    Scoped from an NCI treatment-summary heading. NCI PDQ is an evidence summary, not a practice guideline, and only the dimensions the heading states are part of this definition.
    source wording
    Treatment of Recurrent Malignant Mesothelioma

    Study evidence for this setting

    13 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

    NCT00243074 · Registry condition search · Scope: unclear

    S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00309946 · Registry condition search · Scope: unclear

    Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

    3 outcome links · 1 safety-group records · 1 quality-of-life measures

    →

    NCT00365053 · Registry condition search · Scope: unclear

    PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00392444 · Registry condition search · Scope: unclear

    Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

    1 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00459862 · Registry condition search · Scope: unclear

    Pazopanib in Treating Patients With Malignant Pleural Mesothelioma

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT01064648 · Registry condition search · Scope: unclear

    Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

    6 outcome links · 4 safety-group records · 0 quality-of-life measures

    →

    NCT01112293 · Registry condition search · Scope: unclear

    Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT01861301 · Registry condition search · Scope: unclear

    Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT02399371 · Registry condition search · Scope: unclear

    Pembrolizumab in Treating Patients With Malignant Mesothelioma

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT02408016 · Registry condition search · Scope: unclear

    Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

    6 outcome links · 3 safety-group records · 1 quality-of-life measures

    →

    NCT02535312 · Registry condition search · Scope: unclear

    Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractor

    5 outcome links · 5 safety-group records · 0 quality-of-life measures

    →

    NCT02568449 · Registry condition search · Scope: unclear

    Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent

    4 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT03654833 · Registry condition search · Scope: unclear

    Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

    3 outcome links · 5 safety-group records · 0 quality-of-life measures

    →
    Source relationships and population-mapping limitations
    bindings
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice